$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2017 Form 10-K Financial Statement

#000143774918006054 Filed on April 02, 2018

Income Statement

Concept	2017	2016 Q4	2016
Revenue	$6.303M	$1.700M	$2.976M
YoY Change	111.81%	1.8%	-43.44%
Cost Of Revenue	$3.242M	$310.0K	$729.7K
YoY Change	344.32%	-50.0%	-42.97%
Gross Profit	$3.061M	$1.390M	$2.246M
YoY Change	36.27%	32.38%	-43.59%
Gross Profit Margin	48.56%	81.76%	75.48%
Selling, General & Admin	$5.676M	$1.480M	$4.439M
YoY Change	27.88%	35.78%	7.69%
% of Gross Profit	185.45%	106.47%	197.63%
Research & Development	$1.660M	$420.0K	$2.009M
YoY Change	-17.38%	7.69%	29.11%
% of Gross Profit	54.23%	30.22%	89.44%
Depreciation & Amortization	$52.71K	$10.00K	$49.04K
YoY Change	7.49%	0.0%	14.05%
% of Gross Profit	1.72%	0.72%	2.18%
Operating Expenses	$7.336M	$1.910M	$6.448M
YoY Change	13.78%	29.93%	13.56%
Operating Profit	-$4.275M	-$520.0K	-$4.202M
YoY Change	1.75%	23.81%	147.71%
Interest Expense	$0.00	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$27.00		$12.12K
YoY Change	-99.78%		-107.48%
Pretax Income	-$4.280M	-$520.0K	-$4.190M
YoY Change	2.15%	-14.75%	125.27%
Income Tax	$0.00	$0.00	-$12.12K
% Of Pretax Income
Net Earnings	-$4.275M	-$520.0K	-$4.190M
YoY Change	2.04%	-14.75%	125.58%
Net Earnings / Revenue	-67.83%	-30.59%	-140.79%
Basic Earnings Per Share
Diluted Earnings Per Share	-$5.157M	-$722.2K	-$5.986M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2017	2016 Q4	2016
SHORT-TERM ASSETS
Cash & Short-Term Investments	$290.0K	$1.060M	$1.060M
YoY Change	-72.64%	-75.46%	-75.46%
Cash & Equivalents	$290.0K	$1.061M	$1.060M
Short-Term Investments
Other Short-Term Assets	$2.790M	$53.64K	$1.770M
YoY Change	57.63%	43.34%	-65.29%
Inventory	$950.0K	$465.4K	$470.0K
Prepaid Expenses
Receivables	$2.880M	$1.563M	$1.560M
Other Receivables	$110.0K	$60.00K	$60.00K
Total Short-Term Assets	$7.010M	$4.910M	$4.910M
YoY Change	42.77%	-62.27%	-62.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$180.0K	$67.81K	$70.00K
YoY Change	157.14%	6.16%	16.67%
Goodwill
YoY Change
Intangibles		$134.1K
YoY Change		-9.21%
Long-Term Investments
YoY Change
Other Assets	$10.00K	$10.00K	$10.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$9.070M	$12.38M	$12.38M
YoY Change	-26.74%	67.28%	71.47%
TOTAL ASSETS
Total Short-Term Assets	$7.010M	$4.910M	$4.910M
Total Long-Term Assets	$9.070M	$12.38M	$12.38M
Total Assets	$16.08M	$17.29M	$17.29M
YoY Change	-7.0%	-15.31%	-15.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$500.0K	$466.8K	$470.0K
YoY Change	6.38%	-59.7%	-59.48%
Accrued Expenses	$690.0K	$335.3K	$340.0K
YoY Change	102.94%	-31.99%	-46.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.330M	$1.836M	$1.840M
YoY Change	26.63%	-18.96%	-18.94%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.330M	$1.836M	$1.840M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$2.330M	$1.836M	$1.840M
YoY Change	26.63%	-18.96%	-18.94%
SHAREHOLDERS EQUITY
Retained Earnings		-$62.80M
YoY Change		7.15%
Common Stock		$609.00
YoY Change		10.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.75M	$15.45M	$15.45M
YoY Change
Total Liabilities & Shareholders Equity	$16.08M	$17.29M	$17.29M
YoY Change	-7.0%	-15.31%	-15.33%

Cashflow Statement

Concept	2017	2016 Q4	2016
OPERATING ACTIVITIES
Net Income	-$4.275M	-$520.0K	-$4.190M
YoY Change	2.04%	-14.75%	125.58%
Depreciation, Depletion And Amortization	$52.71K	$10.00K	$49.04K
YoY Change	7.49%	0.0%	14.05%
Cash From Operating Activities	-$2.465M	-$930.0K	-$4.447M
YoY Change	-44.56%	-93.63%	-71.42%
INVESTING ACTIVITIES
Capital Expenditures	$166.1K	$0.00	$52.98K
YoY Change	213.47%		1474.76%
Acquisitions
YoY Change
Other Investing Activities	-$60.00K
YoY Change
Cash From Investing Activities	-$226.8K	$0.00	-$52.98K
YoY Change	328.05%		1474.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.000M		$1.860M
YoY Change	7.53%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.920M	1.810M	1.240M
YoY Change	54.8%	-90.39%	-93.49%
NET CHANGE
Cash From Operating Activities	-2.465M	-930.0K	-4.447M
Cash From Investing Activities	-226.8K	0.000	-52.98K
Cash From Financing Activities	1.920M	1.810M	1.240M
Net Change In Cash	-772.6K	880.0K	-3.260M
YoY Change	-76.3%	-79.29%	-193.74%
FREE CASH FLOW
Cash From Operating Activities	-$2.465M	-$930.0K	-$4.447M
Capital Expenditures	$166.1K	$0.00	$52.98K
Free Cash Flow	-$2.632M	-$930.0K	-$4.500M
YoY Change	-41.52%	-93.63%	-71.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2017	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	138889
CY2017Q4	bkyi	Accrued Factoring Fees Current AccruedFactoringFeesCurrent	32357
CY2016Q4	bkyi	Accrued Factoring Fees Current AccruedFactoringFeesCurrent	3600
CY2017	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	1510051
CY2016	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	21589
CY2016	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod
CY2017Q2	bkyi	Committed Equity Facility Amount CommittedEquityFacilityAmount	5000000
CY2017Q2	bkyi	Committed Equity Facility Term CommittedEquityFacilityTerm	P3Y
CY2017	bkyi	Conversion Of A1 Preferred Dividends Payable Amount Converted ConversionOfA1PreferredDividendsPayableAmountConverted	540000
CY2017	bkyi	Conversion Of Dividends Payable Amount Converted ConversionOfDividendsPayableAmountConverted	540000
CY2016	bkyi	Conversion Of Dividends Payable Amount Converted ConversionOfDividendsPayableAmountConverted
CY2017Q3	bkyi	Conversion Of Dividends Payable Shares Issued ConversionOfDividendsPayableSharesIssued	150000
CY2017	bkyi	Effective Income Tax Reconciliation Effect Of Net Operating Loss EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss	-0.21
CY2016	bkyi	Effective Income Tax Reconciliation Effect Of Net Operating Loss EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss	-0.34
CY2017	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences
CY2016	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences
CY2017Q2	bkyi	Equity Facility Aggregate Sales Limitation Percentage Of Total Outstanding Share EquityFacilityAggregateSalesLimitationPercentageOfTotalOutstandingShare	0.1999
CY2017Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	313484
CY2016Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	160918
CY2017Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	423349
CY2016Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	214556
CY2011Q4	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
CY2011Q4	bkyi	Factoring Arrangement Term FactoringArrangementTerm	P2Y
CY2017	bkyi	Factoring Fees FactoringFees	224142
CY2016	bkyi	Factoring Fees FactoringFees	341023
CY2017	bkyi	Hardware Revenue Net HardwareRevenueNet	1889423
CY2016	bkyi	Hardware Revenue Net HardwareRevenueNet	965489
CY2017	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-74552
CY2016	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights
CY2017Q2	bkyi	Maximum Dollar Amount Of Shares To Purchase Based On Daily Volume Weighted Average Price Of The Companys Common Stock MaximumDollarAmountOfSharesToPurchaseBasedOnDailyVolumeWeightedAveragePriceOfTheCompanysCommonStock	100000
CY2017Q3	bkyi	Maximum Ownership As A Result Of Conversion MaximumOwnershipAsAResultOfConversion	0.0999
CY2017Q4	bkyi	Maximum Ownership As A Result Of Conversion MaximumOwnershipAsAResultOfConversion	0.35
CY2017Q2	bkyi	Maximum Ownership Of Companys Common Stock Requirement Under Committed Equity Facility Sale Percentage MaximumOwnershipOfCompanysCommonStockRequirementUnderCommittedEquityFacilitySalePercentage	0.0999
CY2017	bkyi	Operational Costs Per Month OperationalCostsPerMonth	592000
CY2017Q2	bkyi	Per Share Price That Is Used In Calculation For Purchase Price Under Committed Equity Facility PerSharePriceThatIsUsedInCalculationForPurchasePriceUnderCommittedEquityFacility	3.83
CY2017Q2	bkyi	Percentage Of Lowest Vwap That Equals Or Exceeds Specified Per Share Price Under Committed Equity Facility PercentageOfLowestVWAPThatEqualsOrExceedsSpecifiedPerSharePriceUnderCommittedEquityFacility	0.94
CY2017	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	0.57
CY2017Q2	bkyi	Period For Maximum Dollar Amount Of Shares To Purchase PeriodForMaximumDollarAmountOfSharesToPurchase	P5D
CY2017	bkyi	Reclassification Of Derivative Liability To Additional Paid In Capital ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapital
CY2017	bkyi	Stock Issued Consulting Services StockIssuedConsultingServices	244084
CY2016	bkyi	Stock Issued Consulting Services StockIssuedConsultingServices
CY2017Q2	bkyi	Stock Issued During Period As A Commitment Fee Shares StockIssuedDuringPeriodAsACommitmentFeeShares	55000
CY2017Q2	bkyi	Stock Issued During Period As A Commitment Fee Value StockIssuedDuringPeriodAsACommitmentFeeValue	198000
CY2017Q2	bkyi	Stock Issued During Period Issued For Services Weighted Average Share Price StockIssuedDuringPeriodIssuedForServicesWeightedAverageSharePrice	2.54
CY2016	bkyi	Total Warrants Exercised TotalWarrantsExercised
CY2016	bkyi	Reclassification Of Derivative Liability To Additional Paid In Capital ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapital	92199
CY2017Q4	bkyi	Software License Rights SoftwareLicenseRights	10573808
CY2016Q4	bkyi	Software License Rights SoftwareLicenseRights	12158411
CY2017Q4	bkyi	Software License Rights Current SoftwareLicenseRightsCurrent	2640000
CY2016Q4	bkyi	Software License Rights Current SoftwareLicenseRightsCurrent	1560000
CY2017Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	7933808
CY2016Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	10598411
CY2017	bkyi	Stock Based Fees To Directors And Consulants StockBasedFeesToDirectorsAndConsulants	32030
CY2016	bkyi	Stock Based Fees To Directors And Consulants StockBasedFeesToDirectorsAndConsulants	167000
CY2017	bkyi	Stock Issued Commitment Fee StockIssuedCommitmentFee	198000
CY2016	bkyi	Stock Issued Commitment Fee StockIssuedCommitmentFee
CY2017	bkyi	Total Warrants Exercised TotalWarrantsExercised
CY2016	bkyi	Total Warrants Expired TotalWarrantsExpired	444548
CY2017	bkyi	Total Warrants Expired TotalWarrantsExpired
CY2016	bkyi	Total Warrants Forfeited TotalWarrantsForfeited
CY2017	bkyi	Total Warrants Forfeited TotalWarrantsForfeited
CY2017Q4	bkyi	Warrants Exercisable WarrantsExercisable	1398969
CY2017Q4	bkyi	Warrants Exercisable Weighted Average Exercise Price WarrantsExercisableWeightedAverageExercisePrice	3.81
CY2017	bkyi	Warrants Exercisable Weighted Average Remaining Life WarrantsExercisableWeightedAverageRemainingLife	P2Y21D
CY2015Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	4.40
CY2016Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	3.84
CY2017Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	3.81
CY2015	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P3Y7D
CY2016	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y284D
CY2017	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y21D
CY2017Q4	bkyi	Warrants Vested Or Expected To Vest WarrantsVestedOrExpectedToVest	1398969
CY2017Q4	bkyi	Warrants Vested Or Expected To Vest Weighted Average Exercise Price WarrantsVestedOrExpectedToVestWeightedAverageExercisePrice	3.81
CY2017	bkyi	Warrants Vested Or Expected To Vest Weighted Average Remaining Life WarrantsVestedOrExpectedToVestWeightedAverageRemainingLife	P2Y21D
CY2016	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised
CY2017	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised
CY2016	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	6
CY2017	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired
CY2016	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited
CY2017	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited
CY2016	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted
CY2017	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	3.60
CY2017Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	109865
CY2016Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	53638
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	499230
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	466842
CY2017Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	4649731
CY2016Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3647031
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2889731
CY2016Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1577031
CY2017Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1760000
CY2016Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	2070000
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3635946
CY2016Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3133246
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2875946
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1563246
CY2017Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	760000
CY2016Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	1570000
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	688023
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	335323
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	85633
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	79633
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	341884
CY2016Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	66152
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	605835
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	553126
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	80829001
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	78253413
CY2016	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	92199
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	260842
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	498654
CY2016	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	84866
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	80366
CY2016Q4	us-gaap	Assets Assets	17289365
CY2017Q4	us-gaap	Assets Current AssetsCurrent	7014033
CY2016Q4	us-gaap	Assets Current AssetsCurrent	4910296
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	9064789
CY2016Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	12379069
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	288721
CY2017	us-gaap	Advertising Expense AdvertisingExpense	386000
CY2016	us-gaap	Advertising Expense AdvertisingExpense	299000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	972764
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	427842
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1013785
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	513785
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1000000
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	500000
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13726
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13606
CY2017Q4	us-gaap	Assets Assets	16078822
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1061307
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4321078
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-772586
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3259771
CY2017Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0
CY2016Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	811000
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1704628
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1260080
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1398969
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7691324
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6093843
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7691324
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6093843
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	769
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	609
CY2017Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	164132
CY2016Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	154368
CY2017	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2740400
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	3242151
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	729683
CY2017	us-gaap	Cost Of Services CostOfServices	439291
CY2016	us-gaap	Cost Of Services CostOfServices	216465
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	507866
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	633062
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	46000
CY2016Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	60000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12052000
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18597000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	118000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	67000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	387000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	360000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	277000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	202000
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12862000
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19278000
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18000
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	8000
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2016Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2017	us-gaap	Depreciation Depreciation	52709
CY2016	us-gaap	Depreciation Depreciation	49038
CY2017	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic;">Derivative Liabilities</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">In connection with the issuances of equity instruments or debt, the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>issue options or warrants to purchase common stock. In certain circumstances, these options or warrants <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be classified as liabilities, rather than as equity. In addition, the equity instrument or debt <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>contain embedded derivative instruments, such as conversion options or listing requirements, which in certain circumstances <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be required to be bifurcated from the associated host instrument and accounted for separately as a derivative liability instrument. <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">The Company early-adopted the new provisions issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2017, </div>for derivative liability instruments under FASB ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> Earnings Per Share (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div>), Distinguishing Liabilities from Equity (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">480</div>) and Derivatives and Hedging (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">815</div>): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Non-controlling Interests with a Scope Exception. Under ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> down round features do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> meet the criteria for derivative accounting and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> liability is to be recorded until an actual issuance of securities triggers the down-round feature. Prior to these provisions, the liabilities were recorded without the actual issuance of the securities triggering the down-round feature.</div></div></div></div>
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	630408
CY2016Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	401250
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	630408
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	401250
CY2016	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	802500
CY2017	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	769158
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.76
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.89
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.13
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y69D
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1634611
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	166842
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	153116
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	111000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	14000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	347946
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	287248
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	181104
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	134132
CY2017	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2016	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	12085
CY2017	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives
CY2016	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	12085
CY2017	us-gaap	Gross Profit GrossProfit	3060833
CY2016	us-gaap	Gross Profit GrossProfit	2246073
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	32388
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-691713
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1002700
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	241841
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	352700
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-157745
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-125196
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	256657
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	481419
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	296783
CY2017	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	56227
CY2016	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	16217
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	33472
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	109474
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	181104
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	134132
CY2017	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	27
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	30
CY2017	us-gaap	Interest Paid Net InterestPaidNet
CY2016	us-gaap	Interest Paid Net InterestPaidNet
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	487858
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	381762
CY2017Q4	us-gaap	Inventory Net InventoryNet	946847
CY2016Q4	us-gaap	Inventory Net InventoryNet	465428
CY2017Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	458989
CY2016Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	83666
CY2017Q4	us-gaap	Liabilities Liabilities	2325527
CY2016Q4	us-gaap	Liabilities Liabilities	1836477
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16078822
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17289365
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2325527
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1836477
CY2017	us-gaap	License Costs LicenseCosts	2802860
CY2016	us-gaap	License Costs LicenseCosts	513218
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1919634
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1240034
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-226758
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52975
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2465462
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4446830
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-4275338
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-4189704
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5044496
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4992204
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	27
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12115
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2017	us-gaap	Operating Expenses OperatingExpenses	7336198
CY2016	us-gaap	Operating Expenses OperatingExpenses	6447892
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-4275365
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-4201819
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	225793
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	148862
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	31898
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	45033
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	58403
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4582
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	109865
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	53638
CY2017	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	3220371
CY2016	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	1189089
CY2017	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock
CY2016	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	535100
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	80366
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	84866
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	60698
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	166060
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52975
CY2015Q4	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	180000
CY2017	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	769158
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	802500
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	152654
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	206677
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.</div>  Reclassifications</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">Reclassifications occurred to certain prior year amounts in order to conform to the current year classifications. The reclassifications have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the reported net loss.</div></div></div>
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2000000
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1860000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	787000
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	620940
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	181165
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67814
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	500000
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	500000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1659875
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2008942
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67076492
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62801154
CY2017	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic;">Deferred Revenue</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">Deferred revenue includes customer advances and amounts that have been billed per the contractual terms but have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been recognized as revenue. The majority of these amounts are related to maintenance contracts for which the revenue is recognized ratably over the applicable term, which generally is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months from the date the customer is delivered the products.</div></div></div>
CY2017	us-gaap	Revenues Revenues	6302984
CY2016	us-gaap	Revenues Revenues	2975756
CY2017Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5614
CY2016Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	26988
CY2017	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1193190
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	821178
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	53936
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	364930
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	341663
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1477493
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.87
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.99
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	27087
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.32
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.86
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5676323
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4438950
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	940734
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	260842
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.38
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.93
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0192
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0111
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	261294
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.96
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5667
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	39935
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	21946
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10419
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	72224
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1234167
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.91
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1083691
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.98
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.16
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.50
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.86
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.16
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.62
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.74
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.69
CY2017	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	1.90
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	261294
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1477493
CY2017	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	5.04
CY2017Q4	us-gaap	Share Price SharePrice	1.77
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y186D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y182D
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y32D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y83D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y233D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y156D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	197281
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	285430
CY2017Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	61667
CY2017	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	1610
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4167
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2017Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	156584
CY2016	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	105000
CY2017	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	354585
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1860000
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	62000
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	32030
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	13753295
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	15452888
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	18149917
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">Our consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">’s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates, judgments or assumptions and actual results, its consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require management’s judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> produce a materially different result.</div></div></div></div>
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6638382
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5587144

Files In Submission

Name	View Source	Status
0001437749-18-006054-index-headers.html	Edgar Link	pending
0001437749-18-006054-index.html	Edgar Link	pending
0001437749-18-006054.txt	Edgar Link	pending
0001437749-18-006054-xbrl.zip	Edgar Link	pending
bkyi-20171231.xml	Edgar Link	completed
bkyi-20171231.xsd	Edgar Link	pending
bkyi-20171231_cal.xml	Edgar Link	unprocessable
bkyi-20171231_def.xml	Edgar Link	unprocessable
bkyi-20171231_lab.xml	Edgar Link	unprocessable
bkyi-20171231_pre.xml	Edgar Link	unprocessable
bkyi20171231_10k.htm	Edgar Link	pending
ex_109440.htm	Edgar Link	pending
ex_109441.htm	Edgar Link	pending
ex_109442.htm	Edgar Link	pending
ex_109443.htm	Edgar Link	pending
ex_109534.htm	Edgar Link	pending
ex_109534img001.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2017 Form 10-K Financial Statement

#000143774918006054 Filed on April 02, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2017 Form 10-K Financial Statement

#000143774918006054 Filed on April 02, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi